|
1
|
Ehya F, Abdul Tehrani H, Garshasbi M and
Nabavi SM: Identification of miR-24 and miR-137 as novel candidate
multiple sclerosis miRNA biomarkers using multi-staged data
analysis protocol. Mol Biol Res Commun. 3:127–140. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lassmann H, van HJ and Mahad D:
Progressive multiple sclerosis: Pathology and pathogenesis. Nat Rev
Neurol. 8:647–656. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Oksenberg JR and Barcellos LF: Multiple
sclerosis genetics: Leavin no stone unturned. Genes Immun.
6:375–387. 2005.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Taylor BV: The major cause of multiple
sclerosis is environmental: Genetics has a minor role-yes. Mult
Scler. 17:1171–1173. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
O'Gorman C, Lucas R and Taylor B:
Environmental risk factors for multiple sclerosis: A review with a
focus on molecular mechanisms. Int J Mol Sci. 13:11718–11752.
2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Xu WD, Lu MM, Pan HF and Ye DQ:
Association of MicroRNA-146a with autoimmune diseases.
Inflammation. 35:1525–1529. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Paraboschi EM, Soldà G, Gemmati D, Orioli
E, Zeri G, Benedetti MD, Salviati A, Barizzone N, Leone M, Duga S
and Asselta R: Genetic association and altered gene expression of
mir-155 in multiple sclerosis patients. Int J Mol Sci.
12:8695–8712. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rothchild AC, Sissons JR, Shafiani S,
Plaisier C, Min D, Mai D, Gilchrist M, Peschon J, Larson RP,
Bergthaler A, et al: MiR-155-regulated molecular network
orchestrates cell fate in the innate and adaptive immune response
to Mycobacterium tuberculosis. Proc Natl Acad Sci USA.
113:E6172–E6181. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Min M, Peng L, Yang Y, Guo M, Wang W and
Sun G: MicroRNA-155 is involved in the pathogenesis of ulcerative
colitis by targeting FOXO3a. Inflamm Bowel Dis. 20:652–659.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Murugaiyan G, Beynon V, Mittal A, Joller N
and Weiner HL: Silencing microRNA-155 ameliorates experimental
autoimmune encephalomyelitis. J Immunol. 187:2213–2221.
2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Taganov KD, Boldin MP, Chang KJ and
Baltimore D: NF-κB-dependent induction of microRNA miR-146, an
inhibitor targeted to signaling proteins of innate immune
responses. Proc Natl Acad Sci USA. 103:12481–12486. 2006.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Leng RX, Pan HF, Qin WZ, Chen GM and Ye
DQ: Role of microRNA-155 in autoimmunity. Cytokine Growth Factor
Rev. 22:141–147. 2011.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lescher J, Paap F, Schultz V, Redenbach L,
Scheidt U, Rosewich H, Nessler S, Fuchs E, Gärtner J, Brück W and
Junker A: MicroRNA regulation in experimental autoimmune
encephalomyelitis in mice and marmosets resembles regulation in
human multiple sclerosis lesions. J Neuroimmunol. 246:27–33.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Bell JI: Single nucleotide polymorphisms
and disease gene mapping. Arthritis Res. 4 (Suppl 3):S273–S278.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Labib DA, Shaker OG, El Refai RM, Ghoniem
SA and Elmazny A: Association between miRNA-146a and polymorphisms
of its target gene, IRAK1, regarding susceptibility to and clinical
features of systemic lupus erythematous and multiple sclerosis. Lab
Med. 50:34–41. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Assmann1 TS, Duarte GCK, Brondani LA, de
Freitas PHO, Martins ÉM, Canani1 LH and Crispim D: Polymorphisms in
genes encoding miR-155 and miR-146a are associated with protection
to type 1 diabetes mellitus. Acta Diabetol. 54:433–441.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li Y, Du C, Wang W, Ma G, Cui L, Zhou H,
Tao H, Yao L, Zhao B and Li K: Genetic association of MiR-146a with
multiple sclerosis susceptibility in the Chinese population. Cell
Physiol Biochem. 35:281–291. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Xie K, Ma H, Liang C, Wang C, Qin N, Shen
W, Gu Y, Yan C, Zhang K, Dai N, et al: A functional variant in
miR-155 regulation region contributes to lung cancer risk and
survival. Oncotarget. 6:42781–42792. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ji J, Xu M, Tu J, Zhao Z, Gao J, Chen M,
Song J, Zhu H, Cheng X, Hui J, et al: MiR-155 and its functional
variant rs767649 contribute to the susceptibility and survival of
hepatocellular carcinoma. Oncotarget. 7:60303–60309.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Luo X, Yang W, Ye DQ, Cui H, Zhang Y,
Hirankarn N, Qian X, Tang Y, Lau YL, de Vries N, et al: A
functional variant in microRNA-146a promoter modulates its
expression and confers disease risk for systemic lupus
erythematosus. PLoS Genet. 7(e1002128)2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Golshani Z, Hojati Z, Sharifzadeh A,
Shaygannejad V and Jafarinia M: Genetic variation in intergenic and
exonic miRNA sequence and risk of multiple sclerosis in the isfahan
patients. Iran J Allergy Asthma Immunol. 17:477–484.
2018.PubMed/NCBI
|
|
22
|
McDonald WI, Compston A, Edan G, Goodkin
D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH,
Reingold SC, et al: Recommended diagnostic criteria for multiple
sclerosis: Guidelines from the international panel on the diagnosis
of multiple sclerosis. Ann Neurol. 50:121–127. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Kurtzke JF: Rating neurologic impairment
in multiple sclerosis: An expanded disability status scale (EDSS).
Neurology. 33:1444–1452. 1983.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lotti CBC, Oliveira ASB, Bichuetti DB,
Castro I and Oliveira EML: Late onset multiple sclerosis: Concerns
in aging patients. Arq Neuropsiquiatr. 75:451–456. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hurwitz BJ: The diagnosis of multiple
sclerosis and the clinical subtypes. Ann Indian Acad Neurol.
12:226–230. 2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Puri KS, Suresh KR, Gogtay NJ and Thatte
UM: Declaration of Helsinki, 2008: Implications for stakeholders in
research. J Postgrad Med. 55:131–134. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Shaker OG, El Boghdady NA and El Sayed AE:
Association of MiRNA-146a, MiRNA-499, IRAK1 and PADI4 polymorphisms
with rheumatoid arthritis in Egyptian population. Cell Physiol
Biochem. 46:2239–2249. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Chan YH: Biostatistics 102: Quantitative
data-parametric & non-parametric tests. Singapore Med J.
44:391–396. 2003.PubMed/NCBI
|
|
29
|
Chan YH: Biostatistics 103: Qualitative
data-tests of independence. Singapore Med J. 44:498–503.
2003.PubMed/NCBI
|
|
30
|
Chan YH: Biostatistics 202: Logistic
regression analysis. Singapore Med J. 45:149–153. 2004.PubMed/NCBI
|
|
31
|
Faul F, Erdfelder E, Lang AG and Buchner
A: G*Power 3: A flexible statistical power analysis program for the
social, behavioral, and biomedical sciences. Behav Res Methods.
39:175–191. 2007.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kiselev I, Bashinskaya V, Kulakova O,
Baulina N, Popova E, Boyko A and Favorova O: Variants of MicroRNA
genes: Gender-specific associations with multiple sclerosis risk
and severity. Int J Mol Sci. 16:20067–20081. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhang J, Cheng Y, Cui W, Li M, Li B and
Guo L: MicroRNA-155 modulates Th1 and Th17 cell differentiation and
is associated with multiple sclerosis and experimental autoimmune
encephalomyelitis. J Neuroimmunol. 266:56–63. 2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Shao Y, Li J, Cai Y, Xie Y, Ma G, Li Y,
Chen Y, Liu G, Zhao B, Cui L and Li K: The functional polymorphisms
of miR-146a are associated with susceptibility to severe sepsis in
the Chinese population. Mediators Inflamm.
2014(916202)2014.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ghaffari SA, Nemati M, Hajghani H,
Ebrahimi H, Sheikhi A and Jafarzadeh A: Circulating concentrations
of interleukin (IL)-17 in patients with multiple sclerosis:
Evaluation of the effects of gender, treatment, disease patterns
and IL-23 receptor gene polymorphisms. Iran J Neurol. 16:15–25.
2017.PubMed/NCBI
|
|
36
|
Xia P, Fang X, Zhang ZH, Huang Q, Yan KX,
Kang KF, Han L and Zheng ZZ: Dysregulation of miRNA146a versus
IRAK1 induces IL-17 persistence in the psoriatic skin lesions.
Immunol Lett. 148:151–162. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bove R and Chitnis T: Sexual disparities
in the incidence and course of MS. Clin Immunol. 149:201–210.
2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ysrraelit MC and Correale J: Impact of sex
hormones on immune function and multiple sclerosis development.
Immunology. 156:9–22. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhang C, Zhao J and Deng H: 17β-estradiol
up-regulates miR-155 expression and reduces TP53INP1 expression in
MCF-7 breast cancer cells. Mol Cell Biochem. 379:201–211.
2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Dai R, Phillips RA, Zhang Y, Khan D,
Crasta O and Ahmed SA: Suppression of LPS-induced Interferon-gamma
and nitric oxide in splenic lymphocytes by select
estrogen-regulated microRNAs: A novel mechanism of immune
modulation. Blood. 112:4591–4597. 2008.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kangas R, Pöllänen E, Rippo MR, Lanzarini
C, Prattichizzo F, Niskala P, Jylhävä J, Sipilä S, Kaprio J,
Procopio AD, et al: Circulating miR-21, miR-146a and Fas ligand
respond to postmenopausal estrogen-based hormone replacement
therapy-a study with monozygotic twin pairs. Mech Ageing Dev.
143-144:1–8. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Bsteh G, Ehling R, Lutterotti A, Hegen H,
Di Pauli F, Auer M, Deisenhammer F, Reindl M and Berger T: Long
term clinical prognostic factors in relapsing-remitting multiple
sclerosis: Insights from a 10-year observational study. PLoS One.
11(e0158978)2016.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Chen C, Zhou Y, Wang J, Yan Y, Peng L and
Qiu W: Dysregulated MicroRNA involvement in multiple sclerosis by
induction of T helper 17 cell differentiation. Front Immunol.
9(1256)2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Goodin DS, Reder AT, Bermel RA, Cutter GR,
Fox RJ, John GR, Lublin FD, Lucchinetti CF, Miller AE, Pelletier D,
et al: Relapses in multiple sclerosis: Relationship to disability.
Mult Scler Relat Disord. 6:10–20. 2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Karkeni E, Bonnet L, Marcotorchino J,
Tourniaire F, Astier J, Ye J and Landrier JF: Vitamin D limits
inflammation-linked microRNA expression in adipocytes in vitro and
in vivo: A new mechanism for the regulation of inflammation by
vitamin D. Epigenetics. 13:156–162. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lu F, Weidmer A, Liu CG, Volinia S, Croce
CM and Lieberman PM: Epstein-Barr virus-induced miR-155 attenuates
NF-kappaB signaling and stabilizes latent virus persistence. J
Virol. 82:10436–20443. 2008.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Momi N, Kaur S, Rachagani S, Ganti AK and
Batra SK: Smoking and microRNA dysregulation: A cancerous
combination. Trends Mol Med. 20:36–47. 2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Harbo HF, Gold R and Tintoré M: Sex and
gender issues in multiple sclerosis. Ther Adv Neurol Disord.
6:237–248. 2013.PubMed/NCBI View Article : Google Scholar
|
